Literature DB >> 9004179

Development in a 46 XX boy with positive SRY gene.

A Rego1, E Margarit, X Estivill, M Regal, R V García-Mayor.   

Abstract

We present the case of an 11 year-old boy, who asked for medical attention due to obesity and assumed underdeveloped external genitalia. He did not have genital anomalies, penile length was 5.3 cm, testicular volume 2 ml and pubic hair Tanner stage 1. His bone age was normal for chronological age. Endocrinological study showed normal results for his age. Karyotype revealed a 46 XX pattern. MRI of external genitalia showed bilateral scrotal testes which were normal in diameter for his age. The check of his historical growth chart and follow-up revealed normal growth with spontaneous pubertal development. However, hormonal studies showed progressive increase of FSH levels, indicative of failure of germinal epithelium. The presence of Y sequences, including SRY gene, was demonstrated by PCR. Our observation is in agreement with the view that 46 XX male subjects diagnosed at peripubertal age with the SRY gene in the genome have a good prognosis regarding growth and development, but the principal problem of these patients is infertility.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9004179     DOI: 10.1515/jpem.1996.9.6.623

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  3 in total

1.  Molecular, cytogenetic, and clinical characterisation of six XX males including one prenatal diagnosis.

Authors:  E Margarit; A Soler; A Carrió; R Oliva; D Costa; T Vendrell; J Rosell; F Ballesta
Journal:  J Med Genet       Date:  1998-09       Impact factor: 6.318

2.  46,XX, der(15),t(Y;15)(q12;p11) karyotype in an azoospermic male.

Authors:  Serap T Onrat; Zafer Söylemez; Muhsin Elmas
Journal:  Indian J Hum Genet       Date:  2012-05

3.  Ten cases with 46,XX testicular disorder of sex development: single center experience.

Authors:  Emre Can Akinsal; Numan Baydilli; Abdullah Demirtas; Cetin Saatci; Oguz Ekmekcioglu
Journal:  Int Braz J Urol       Date:  2017 Jul-Aug       Impact factor: 1.541

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.